Incannex Healthcare IXHL
NASDAQ IXHL
$3.25 +0.01 (+0.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Equity Income (2025 - 2026)

Updated

Incannex Healthcare (IXHL) posted Equity Income of -$9,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Incannex Healthcare (IXHL) Equity Income (2025 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Incannex Healthcare's Equity Income came in at -$37,000.

  • Quarterly Equity Income has run from a low of -$44,000 in fiscal Q3 2026 to a high of $11,000 in fiscal Q2 2026 over five years.
  • According to Business Quant data, Equity Income for the three prior fiscal quarters was -$44,000 (Q3 2026), $11,000 (Q2 2026) and $6,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Incannex Healthcare 40.64 Mn 40.64 Mn - -9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9,000.00
Mar 31, 2026 -44,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 6,000.00
API Access

Incannex Healthcare Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=IXHL&period=max&api_key=YOUR_API_KEY